HEALTHNews in brief - Dec. 8, 2003Wyeth announces delays in pneumococcal vaccine delivery - Young breast cancer survivors more likely to face problems Wyeth announces delays in pneumococcal vaccine deliveryPhysicians are experiencing two-week delays between order placement and shipping of the pneumococcal conjugate vaccine, Prevnar, according to a statement issued by the manufacturer Wyeth. The delay is due to changes in the company's quality assurance procedures. Shipments should resume their regular schedule soon. No shortages are expected, although the Centers for Disease Control and Prevention is monitoring the situation.Wyeth is the only manufacturer of the vaccine. Young breast cancer survivors more likely to face problemsWomen diagnosed with breast cancer in their late 20s and early 30s were more likely to have a lower quality of life over the long term, according to a study in the November Journal of Clinical Oncology. Researchers at the University of California, Los Angeles, surveyed nearly 600 women who were younger than 50 at the time of diagnosis about their emotional, mental and physical health as well as their outlook on life and sexual activity. Women in the study were doing well, but those ages 25 to 34, tended to be more likely to experience persistent fatigue and poor emotional functioning. Women who were African-American or in a committed relationship were more likely to have a higher quality of life. Copyright 2003 American Medical Association. All rights reserved.
|
Featured stories     
« Prev
1
2
3
4
5
6
Next »
Current topicsMost-viewed
This weekMedicaid primary care pay: The next SGR? More newborns showing ill effects of maternal opioid use Get our email alertsUse our one-step registration. Learn more Your information will not be shared. Privacy policyColumns and series
From the vault |
|||||||||
